[1]
Ladrière M. [Current indications of azathioprine in nephrology]. Nephrologie & therapeutique. 2013 Feb:9(1):8-12. doi: 10.1016/j.nephro.2012.08.002. Epub 2012 Sep 28
[PubMed PMID: 23022291]
[2]
Anstey AV, Wakelin S, Reynolds NJ, British Association of Dermatologists Therapy, Guidelines and Audit Subcommittee. Guidelines for prescribing azathioprine in dermatology. The British journal of dermatology. 2004 Dec:151(6):1123-32
[PubMed PMID: 15606506]
[3]
Schmidt C, Herrlinger K, Siegmund B, Bokemeyer B, Schreiber S, Stallmach A, Kompetenznetz Darmerkrankungen. [Azathioprine in Crohn's disease therapy--guidance against the background of recent studies]. Zeitschrift fur Gastroenterologie. 2014 Dec:52(12):1423-30. doi: 10.1055/s-0034-1385650. Epub 2014 Dec 4
[PubMed PMID: 25474282]
[4]
Sheiko MA, Sundaram SS, Capocelli KE, Pan Z, McCoy AM, Mack CL. Outcomes in Pediatric Autoimmune Hepatitis and Significance of Azathioprine Metabolites. Journal of pediatric gastroenterology and nutrition. 2017 Jul:65(1):80-85. doi: 10.1097/MPG.0000000000001563. Epub
[PubMed PMID: 28272159]
[5]
Aljumah AA, Al Jarallah B, Albenmousa A, Al Khathlan A, Al Zanbagi A, Al Quaiz M, Al-Judaibi B, Nabrawi K, Al Hamoudi W, Alghamdi M, Fallatah H. The Saudi association for the study of liver diseases and transplantation clinical practice guidelines for management of autoimmune hepatitis. Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association. 2018 Nov:24(7 Suppl):S1-S20. doi: 10.4103/sjg.SJG_159_18. Epub
[PubMed PMID: 30264737]
Level 1 (high-level) evidence
[6]
Cooper N. State of the art - how I manage immune thrombocytopenia. British journal of haematology. 2017 Apr:177(1):39-54. doi: 10.1111/bjh.14515. Epub 2017 Mar 10
[PubMed PMID: 28295192]
[7]
Oldham JM, Lee C, Valenzi E, Witt LJ, Adegunsoye A, Hsu S, Chen L, Montner S, Chung JH, Noth I, Vij R, Strek ME. Azathioprine response in patients with fibrotic connective tissue disease-associated interstitial lung disease. Respiratory medicine. 2016 Dec:121():117-122. doi: 10.1016/j.rmed.2016.11.007. Epub 2016 Nov 4
[PubMed PMID: 27888985]
[8]
Imazio M, Lazaros G, Brucato A, Gaita F. Recurrent pericarditis: new and emerging therapeutic options. Nature reviews. Cardiology. 2016 Feb:13(2):99-105. doi: 10.1038/nrcardio.2015.115. Epub 2015 Aug 11
[PubMed PMID: 26259934]
[9]
Touhami S, Diwo E, Sève P, Trad S, Bielefeld P, Sène D, Abad S, Brézin A, Quartier P, Koné Paut I, Weber M, Chiquet C, Errera MH, Sellam J, Cacoub P, Kaplanski G, Kodjikian L, Bodaghi B, Saadoun D. Expert opinion on the use of biological therapy in non-infectious uveitis. Expert opinion on biological therapy. 2019 May:19(5):477-490. doi: 10.1080/14712598.2019.1595578. Epub 2019 Apr 16
[PubMed PMID: 30888881]
Level 3 (low-level) evidence
[10]
Mathian A,Miyara M,Cohen-Aubart F,Haroche J,Hie M,Pha M,Grenier P,Amoura Z, Relapsing polychondritis: A 2016 update on clinical features, diagnostic tools, treatment and biological drug use. Best practice
[PubMed PMID: 27886803]
[11]
Meggitt SJ, Anstey AV, Mohd Mustapa MF, Reynolds NJ, Wakelin S. British Association of Dermatologists' guidelines for the safe and effective prescribing of azathioprine 2011. The British journal of dermatology. 2011 Oct:165(4):711-34. doi: 10.1111/j.1365-2133.2011.10575.x. Epub
[PubMed PMID: 21950502]
[12]
Ruemmele FM, Veres G, Kolho KL, Griffiths A, Levine A, Escher JC, Amil Dias J, Barabino A, Braegger CP, Bronsky J, Buderus S, Martín-de-Carpi J, De Ridder L, Fagerberg UL, Hugot JP, Kierkus J, Kolacek S, Koletzko S, Lionetti P, Miele E, Navas López VM, Paerregaard A, Russell RK, Serban DE, Shaoul R, Van Rheenen P, Veereman G, Weiss B, Wilson D, Dignass A, Eliakim A, Winter H, Turner D, European Crohn's and Colitis Organisation, European Society of Pediatric Gastroenterology, Hepatology and Nutrition. Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease. Journal of Crohn's & colitis. 2014 Oct:8(10):1179-207. doi: 10.1016/j.crohns.2014.04.005. Epub 2014 Jun 6
[PubMed PMID: 24909831]
Level 3 (low-level) evidence
[13]
Wee JS, Marinaki A, Smith CH. Life threatening myelotoxicity secondary to azathioprine in a patient with atopic eczema and normal thiopurine methyltransferase activity. BMJ (Clinical research ed.). 2011 Mar 25:342():d1417. doi: 10.1136/bmj.d1417. Epub 2011 Mar 25
[PubMed PMID: 21441287]
[14]
Williet N, Roblin X. Trend towards dose reduction of azathioprine as monotherapy in inflammatory bowel disease patients: what about for combination therapy? Therapeutic advances in gastroenterology. 2017 Jan:10(1):5-10. doi: 10.1177/1756283X16670074. Epub 2016 Oct 10
[PubMed PMID: 28286554]
Level 3 (low-level) evidence
[15]
Joshi R, Singh S. Plica Neuropathica (Plica polonica) Following Azathioprine-induced Pancytopenia. International journal of trichology. 2010 Jul:2(2):110-2. doi: 10.4103/0974-7753.77523. Epub
[PubMed PMID: 21712900]
[16]
Steponaitiene R, Kupcinskas J, Survilaite S, Varkalaite G, Jonaitis L, Kiudelis G, Denapiene G, Valantinas J, Skieceviciene J, Kupcinskas L. TPMT and ITPA genetic variants in Lithuanian inflammatory bowel disease patients: Prevalence and azathioprine-related side effects. Advances in medical sciences. 2016 Mar:61(1):135-40. doi: 10.1016/j.advms.2015.09.008. Epub 2015 Dec 10
[PubMed PMID: 26674571]
Level 3 (low-level) evidence
[17]
. Guidelines for monitoring drug therapy in rheumatoid arthritis. American College of Rheumatology Ad Hoc Committee on Clinical Guidelines. Arthritis and rheumatism. 1996 May:39(5):723-31
[PubMed PMID: 8639168]
[18]
Melzer N, Ruck T, Fuhr P, Gold R, Hohlfeld R, Marx A, Melms A, Tackenberg B, Schalke B, Schneider-Gold C, Zimprich F, Meuth SG, Wiendl H. Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the Guidelines of the German Neurological Society. Journal of neurology. 2016 Aug:263(8):1473-94. doi: 10.1007/s00415-016-8045-z. Epub 2016 Feb 17
[PubMed PMID: 26886206]
[19]
Broekman MMTJ, Coenen MJH, van Marrewijk CJ, Wanten GJA, Wong DR, Verbeek ALM, Klungel OH, Hooymans PM, Guchelaar HJ, Scheffer H, Derijks LJJ, de Jong DJ, TOPIC Recruitment Team. More Dose-dependent Side Effects with Mercaptopurine over Azathioprine in IBD Treatment Due to Relatively Higher Dosing. Inflammatory bowel diseases. 2017 Oct:23(10):1873-1881. doi: 10.1097/MIB.0000000000001163. Epub
[PubMed PMID: 28644183]
[20]
Weinshilboum RM, Sladek SL. Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity. American journal of human genetics. 1980 Sep:32(5):651-62
[PubMed PMID: 7191632]
[21]
Nielsen OH, Vainer B, Rask-Madsen J. Review article: the treatment of inflammatory bowel disease with 6-mercaptopurine or azathioprine. Alimentary pharmacology & therapeutics. 2001 Nov:15(11):1699-708
[PubMed PMID: 11683683]
[22]
Saway PA, Heck LW, Bonner JR, Kirklin JK. Azathioprine hypersensitivity. Case report and review of the literature. The American journal of medicine. 1988 May:84(5):960-4
[PubMed PMID: 3284343]
Level 3 (low-level) evidence
[23]
González-Olivares M, Khedaoui R, Martínez-Morán C, Borbujo J. Azathioprine-Induced Hypersensitivity Reaction Presenting as Erythema Nodosum. Actas dermo-sifiliograficas. 2017 Jul-Aug:108(6):591-593. doi: 10.1016/j.ad.2016.12.006. Epub 2017 Mar 2
[PubMed PMID: 28262113]
[24]
Karaahmet F, Akinci H, Ayte R, Hamamci M, Coskun Y, Yuksel I. Tremor as dose dependent side-effect of azathioprine in remission patient with ileal Crohn's disease. Journal of Crohn's & colitis. 2013 Oct:7(9):e404. doi: 10.1016/j.crohns.2013.04.010. Epub 2013 Apr 26
[PubMed PMID: 23623283]
[25]
Fuggle NR, Bragoli W, Mahto A, Glover M, Martinez AE, Kinsler VA. The adverse effect profile of oral azathioprine in pediatric atopic dermatitis, and recommendations for monitoring. Journal of the American Academy of Dermatology. 2015 Jan:72(1):108-14. doi: 10.1016/j.jaad.2014.08.048. Epub 2014 Nov 4
[PubMed PMID: 25440430]
[26]
Trivedi CD, Pitchumoni CS. Drug-induced pancreatitis: an update. Journal of clinical gastroenterology. 2005 Sep:39(8):709-16
[PubMed PMID: 16082282]
[27]
van Geenen EJ, de Boer NK, Stassen P, Linskens RK, Bruno MJ, Mulder CJ, Stegeman CA, van Bodegraven AA. Azathioprine or mercaptopurine-induced acute pancreatitis is not a disease-specific phenomenon. Alimentary pharmacology & therapeutics. 2010 Jun:31(12):1322-9. doi: 10.1111/j.1365-2036.2010.04287.x. Epub 2010 Mar 6
[PubMed PMID: 20222913]
[28]
Gupta P, Shaffrali F. An unusual side effect of azathioprine. Clinical and experimental dermatology. 2015 Dec:40(8):929-30. doi: 10.1111/ced.12639. Epub 2015 Mar 21
[PubMed PMID: 25810100]
[29]
van der Woude CJ, Ardizzone S, Bengtson MB, Fiorino G, Fraser G, Katsanos K, Kolacek S, Juillerat P, Mulders AG, Pedersen N, Selinger C, Sebastian S, Sturm A, Zelinkova Z, Magro F, European Crohn’s and Colitis Organization. The second European evidenced-based consensus on reproduction and pregnancy in inflammatory bowel disease. Journal of Crohn's & colitis. 2015 Feb:9(2):107-24
[PubMed PMID: 25602023]
Level 3 (low-level) evidence
[30]
Provan D,Stasi R,Newland AC,Blanchette VS,Bolton-Maggs P,Bussel JB,Chong BH,Cines DB,Gernsheimer TB,Godeau B,Grainger J,Greer I,Hunt BJ,Imbach PA,Lyons G,McMillan R,Rodeghiero F,Sanz MA,Tarantino M,Watson S,Young J,Kuter DJ, International consensus report on the investigation and management of primary immune thrombocytopenia. Blood. 2010 Jan 14;
[PubMed PMID: 19846889]
Level 3 (low-level) evidence
[32]
Menter A, Korman NJ, Elmets CA, Feldman SR, Gelfand JM, Gordon KB, Gottlieb AB, Koo JY, Lebwohl M, Lim HW, Van Voorhees AS, Beutner KR, Bhushan R. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents. Journal of the American Academy of Dermatology. 2009 Sep:61(3):451-85. doi: 10.1016/j.jaad.2009.03.027. Epub 2009 Jun 3
[PubMed PMID: 19493586]
[33]
Jack KL, Koopman WJ, Hulley D, Nicolle MW. A Review of Azathioprine-Associated Hepatotoxicity and Myelosuppression in Myasthenia Gravis. Journal of clinical neuromuscular disease. 2016 Sep:18(1):12-20. doi: 10.1097/CND.0000000000000133. Epub
[PubMed PMID: 27552384]
[34]
Gregoriano C, Ceschi A, Rauber-Lüthy C, Kupferschmidt H, Banner NR, Krähenbühl S, Taegtmeyer AB. Acute thiopurine overdose: analysis of reports to a National Poison Centre 1995-2013. PloS one. 2014:9(1):e86390. doi: 10.1371/journal.pone.0086390. Epub 2014 Jan 29
[PubMed PMID: 24489721]